Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

8:45 AM ET 8-K
Loan & Debt AMC Robotics Corp AMCI

AMC Robotics $3.88M Debt Financing with Ayame Asset Holdings LLC

AMC Robotics entered into a $50 million standby equity purchase agreement (SEPA) and concurrently issued $3.88 million in convertible promissory notes to Ayame Asset Holdings LLC. The proceeds from the notes will be used to accelerate the buildout and commissioning of the company's robotic manufacturing facility, expected to be completed by November 2026.

Value
$3.88M
Counterparty
Ayame Asset Holdings LLC
Term
1 year
8:43 AM ET 8-K
Investor Presentation Burke & Herbert Financial Services Corp. BHRB

Burke & Herbert Financial Services Investor Presentation

Burke & Herbert Financial Services Corp. filed a formal investor presentation to be used by management during meetings with investors and analysts throughout the third quarter of 2026. The presentation provides strategic and financial information following the company's merger with LINKBANCORP, Inc. to assist stakeholders in understanding the combined entity's performance and outlook.

8:43 AM ET 8-K
Executive Compensation Valero Energy Corp VLO

Valero Energy Executive Compensation

Valero Energy Corporation elected Matthew Audette to its Board of Directors and appointed him to the Audit Committee. The company disclosed his initial compensation package, including a pro-rata cash retainer of $101,667 and 372 stock units, while also announcing a $10,000 increase to both the annual cash and equity components of its non-employee director compensation program starting in 2027.

Counterparty
Matthew Audette
Term
through 2027 Annual Meeting
8:39 AM ET 8-K
Financial Results Progressive Corp PGR

Progressive Financial Results

The Progressive Corporation reported financial results for the month ended August 31, 2026, with net income of $951 million ($1.63 per share) on net premiums earned of $7.35 billion. The company's combined ratio for the month was 89.3, and total policies in force grew 7% year-over-year to 40.5 million.

Term
August 2026
8:33 AM ET 8-K
Leadership Change Smith Micro Software, Inc. SMSI

Smith Micro Software Leadership Change

Smith Micro Software announced that its founder, William W. Smith, Jr., has returned as President and CEO, succeeding Timothy C. Huffmyer who resigned to pursue other opportunities. Mr. Smith previously led the company for over 40 years and had been serving as Executive Chairman since March 2026. Mr. Huffmyer will remain on the company's Board of Directors.

8:30 AM ET Form 4
Insider Buying Karman Holdings Inc. KRMN

Karman Holdings Director David Stinnett Buys $1.01M of Stock

David Stinnett, Director, bought 27,000 shares of Karman Holdings Inc. at $37.32 a share, worth $1.01M in total on Sep 16, 2026. Shares held after the trade: 3,530,395 (+0.8%).

Value
$1.01M
Shares
27,000
Price
$37.32
Role
Director
Holding change
+0.8%
Trade date
Sep 16, 2026
8:29 AM ET Form 4
Insider Buying Karman Holdings Inc. KRMN

Karman Holdings Director Mary D. Petryszyn Buys $18.7K of Stock

Mary D. Petryszyn, Director, bought 500 shares of Karman Holdings Inc. at $37.44 a share, worth $18.7K in total on Sep 16, 2026. Shares held after the trade: 2,863 (+21.2%).

Value
$18.7K
Shares
500
Price
$37.44
Role
Director
Holding change
+21.2%
Trade date
Sep 16, 2026
8:28 AM ET Form 4
Insider Buying Karman Holdings Inc. KRMN

Karman Holdings Director Stephen Twitty Buys $10.1K of Stock

Stephen Twitty, Director, bought 275 shares of Karman Holdings Inc. at $36.79 a share, worth $10.1K in total on Sep 16, 2026. Shares held after the trade: 2,638 (+11.6%).

Value
$10.1K
Shares
275
Price
$36.79
Role
Director
Holding change
+11.6%
Trade date
Sep 16, 2026
8:24 AM ET 8-K
Loan & Debt Halozyme Therapeutics, Inc. HALO

Halozyme Therapeutics $1.5B Debt Financing

Halozyme Therapeutics priced an upsized private offering of $1.3 billion in 1.50% convertible senior notes due 2033, with an additional $200 million option granted to initial purchasers. The company entered into capped call transactions to manage potential dilution, with an initial cap price representing a 90% premium over the current stock price. Proceeds are intended for general corporate purposes, which may include debt repayment or share repurchases.

Value
$1.5B
Term
through Oct 2033
8:06 AM ET 8-K
Reverse Stock Split VisionWave Holdings, Inc. VWAV

VisionWave Holdings Reverse Stock Split

VisionWave Holdings, Inc. is implementing a 1-for-20 reverse stock split of its common stock, effective September 22, 2026. The split is intended to increase the per-share trading price to maintain compliance with Nasdaq's $1.00 minimum bid price requirement. The action will reduce the outstanding share count from approximately 47.5 million to 2.4 million shares.

8:05 AM ET 8-K
Dividend Philip Morris International Inc. PM

Philip Morris International Dividend

Philip Morris International's Board of Directors declared a quarterly dividend of $1.60 per share, representing an 8.8% increase from the previous $1.47 per share. The dividend is payable on October 26, 2026, to shareholders of record as of October 2, 2026, bringing the annualized rate to $6.40 per share.

8:04 AM ET 8-K
Other 8-K Filing Zcash ETF ZCSH

Zcash ETF Other 8-K Filing

The Zcash ETF announced a 3-for-1 forward share split for shareholders of record as of September 28, 2026. The split will be payable on September 29, 2026, and shares will begin trading on a split-adjusted basis on September 30, 2026. The action will triple the number of outstanding shares and reduce the price per share by approximately two-thirds without changing the total value of shareholder investments.

8:02 AM ET 8-K
Other 8-K Filing Pmgc Holdings Inc. ELAB

Pmgc Holdings Other 8-K Filing

PMGC Holdings and its subsidiary NorthStrive Biosciences entered into a binding payment agreement with Longevity Health Holdings to secure royalty payments from the 2025 sale of the Elevai Skincare business. The agreement converts a 5% net sales royalty into scheduled monthly cash payments through August 2031, including interest and mandatory prepayments tied to future capital events. This restructuring provides PMGC with visible, non-dilutive cash flow while allowing it to focus on its core manufacturing and defense technology segments.

Counterparty
Longevity Health Holdings, Inc.
Term
through Aug 2031
7:53 AM ET Form 4
Insider Buying Truist Financial Corp TFC

Truist Financial President & CEO Michael P. Lyons Buys $1.02M of Stock

Michael P. Lyons, President & CEO, bought 21,000 shares of Truist Financial Corp at $48.36 a share, worth $1.02M in total on Sep 17, 2026. Shares held after the trade: 21,000.

Value
$1.02M
Shares
21,000
Price
$48.36
Role
President & CEO
Trade date
Sep 17, 2026
7:45 AM ET 8-K
Product Launch Beneficient BENF

Beneficient Product Launch

Beneficient announced the upcoming launch of AltLens, a technology-enabled alternative asset portfolio analytics and risk platform designed for family offices and small institutional investors. The platform, scheduled to go live in Q4 2026, provides institutional-level risk modeling, stress-testing, and allocation analysis based on historical private market data. This launch aims to capture growing demand for sophisticated oversight tools as global alternative assets under management are projected to reach $29 trillion by 2029.

7:43 AM ET Form 4
Insider Selling Scorpio Tankers Inc. STNG

Scorpio Tankers Secretary Auste Adelborg Sells $613K of Stock

Auste Adelborg, Secretary, sold 6,834 shares of Scorpio Tankers Inc. at $89.64 a share, worth $613K in total on Sep 17, 2026. Shares held after the trade: 0 (-100.0%).

Value
$613K
Shares
6,834
Price
$89.64
Role
Secretary
Holding change
-100.0%
Trade date
Sep 17, 2026
7:37 AM ET 8-K
Loan & Debt Ready Capital Corp RC

Ready Capital $225M Debt Financing with UMB Bank, N.A.

Ready Capital's subsidiary priced a private placement of $225 million in 10.00% Senior Secured Notes due 2031. The proceeds will be used to redeem $350 million of existing 4.50% Senior Secured Notes due 2026, marking a significant milestone in the company's balance sheet repositioning and deleveraging plan.

Value
$225M
Counterparty
UMB Bank, N.A.
Term
through 2031
7:27 AM ET Form 4
Insider Selling Icon PLC ICLR

Icon Insider John Dr Climax Sells $876K of Stock

John Dr Climax sold 5,005 shares of Icon PLC at $175.00 a share, worth $876K in total on Sep 16, 2026. Shares held after the trade: 2,087 (-70.6%).

Value
$876K
Shares
5,005
Price
$175.00
Holding change
-70.6%
Trade date
Sep 16, 2026
7:27 AM ET Form 4
Insider Selling Similarweb Ltd. SMWB

Similarweb CEO Or Offer Sells $638K of Stock

Or Offer, CEO, sold 76,119 shares of Similarweb Ltd. at $8.35 to $8.40 a share (average $8.38) in 2 transactions, worth $638K in total between Sep 16, 2026 and Sep 17, 2026. Shares held after the trade: 4,177,381 (-0.7%).

Value
$638K
Shares
76,119
Average price
$8.38
Role
CEO
Holding change
-0.7%
Trade date
Sep 16, 2026 to Sep 17, 2026
7:27 AM ET Form 4
Insider Buying Baozun Inc. BZUN

Baozun CEO Wenbin Qiu Buys $40.2K of Stock

Wenbin Qiu, CEO, bought 14,400 shares of Baozun Inc. at $2.74 to $2.84 a share (average $2.79) in 2 transactions, worth $40.2K in total between Sep 16, 2026 and Sep 17, 2026. Shares held after the trade: 1,652,872 (+0.4%).

Value
$40.2K
Shares
14,400
Average price
$2.79
Role
CEO
Holding change
+0.4%
Trade date
Sep 16, 2026 to Sep 17, 2026
7:27 AM ET Form 4
Insider Selling Radware Ltd RDWR

Radware CTO David Meleh Aviv Sells $461K of Stock

David Meleh Aviv, CTO, sold 15,000 shares of Radware Ltd at $30.71 a share, worth $461K in total on Sep 17, 2026. Shares held after the trade: 134,487 (-10.0%).

Value
$461K
Shares
15,000
Price
$30.71
Role
CTO
Holding change
-10.0%
Trade date
Sep 17, 2026
7:15 AM ET 8-K
Financial Results BlossomHill Therapeutics, Inc. BLSM

BlossomHill Therapeutics Financial Results

BlossomHill Therapeutics reported financial results for the second quarter of 2026, highlighting the successful completion of its $168.3 million IPO in August. The company also noted clinical progress for BH-30643, which received FDA Fast Track designation for the treatment of advanced EGFR C797S-positive NSCLC.

Term
Q2 2026

“We’ve achieved meaningful progress across our pipeline, as well as our significant corporate milestones, since the beginning of the second quarter. In April, we presented our first preclinical data from our pseudo-irreversible pan-KRAS inhibitor BH-501284, built on a novel chemical scaffold, at AACR where we highlighted the sustained target engagement leading to tumor regression at low dose levels.”

Jean Cui, Ph.D., Founder, President and Chief Executive Officer

“With a strong balance sheet following our successful initial public offering in August, we believe we are well positioned to deliver important clinical and regulatory milestones over the coming quarters as we continue advancing our intentionally designed medicines that address significant unmet medical needs in cancer treatment.”

Jean Cui, Ph.D., Founder, President and Chief Executive Officer
7:14 AM ET 8-K
Shareholder Meeting Roivant Sciences Ltd. ROIV

Roivant Sciences Shareholder Meeting

Roivant Sciences Ltd. held its 2026 Annual General Meeting of Shareholders on September 16, 2026, where shareholders approved all three agenda proposals. Key outcomes included the re-election of Daniel Gold and Meghan FitzGerald as Class II directors, the ratification of Ernst & Young LLP as the independent auditor, and the advisory approval of executive compensation.

7:05 AM ET 8-K
Stock Buyback Cava Group, Inc. CAVA

Cava Group Announces $100M Stock Buyback

CAVA Group's Board of Directors has authorized a new share repurchase program to buy back up to $100 million of its common stock. The program is set to expire on September 17, 2027, and will be funded through existing cash and operational cash flows.

Value
$100M
Term
through Sep 2027
6:58 AM ET 8-K
Other 8-K Filing Sunshine Silver Mining & Refining Co SSMR

Sunshine Silver Mining & Refining Other 8-K Filing

Sunshine Silver Mining & Refining Company announced its inclusion in the VanEck Junior Gold Miners ETF (GDXJ), effective September 18, 2026. The inclusion occurs three months after the company's IPO and is expected to increase investor visibility and trading liquidity. Management remains focused on returning the Sunshine Mine to production by late 2028.

Counterparty
VanEck Junior Gold Miners ETF
6:53 AM ET 8-K
Leadership Change Pentair plc PNR

Pentair Leadership Change

Pentair plc appointed Louis V. Pinkham to its Board of Directors and the Audit and Finance Committee, effective September 17, 2026. Mr. Pinkham is classified as an independent director and will receive the company's standard non-employee director compensation.

Counterparty
Louis V. Pinkham
6:46 AM ET 8-K
Investor Presentation Nova Minerals Corp NVA

Nova Minerals Investor Presentation

Nova Minerals Corp filed a formal corporate presentation dated September 18, 2026, as an exhibit to its 8-K. The presentation provides a strategic update on the company's operations and was also made available on its corporate website.

6:45 AM ET 8-K
Leadership Change Adient plc ADNT

Adient Leadership Change

Adient plc announced that Peter H. Carlin will resign from the board of directors to join the company as Vice President, Finance on October 1, 2026, before being appointed Executive Vice President and CFO on November 16, 2026. He succeeds Mark A. Oswald, whose departure was previously announced. Carlin's compensation package includes an $820,000 base salary and a $4.25 million target equity award for fiscal 2027.

6:05 AM ET 8-K
Partnership Paradium.AI, Inc. PAAI

Paradium.AI Partnership with RTB Digital, Inc.

Paradium.AI entered into a 10-year strategic platform agreement with RTB Digital (Roundtable) to form a strategic operating relationship where Roundtable will provide technology and monetization services for Paradium's media brands. Alongside the partnership, Roundtable is acquiring a 49.5% minority stake in Paradium.AI from an existing shareholder at $3.80 per share, though Paradium.AI remains an independent entity and will receive Roundtable stock in exchange for a technology license.

Counterparty
RTB Digital, Inc. (Roundtable)
Term
10 years
6:04 AM ET 8-K
Loan & Debt Evolution Metals & Technologies Corp. EMAT

Evolution Metals & Technologies $30.9M Debt Financing with Ya II Pn, Ltd.

Evolution Metals & Technologies Corp. entered into a securities purchase agreement with Yorkville for the issuance of convertible debentures in the aggregate principal amount of approximately $30.9 million. The financing consists of an initial $22 million tranche issued immediately, with subsequent tranches totaling approximately $8.9 million contingent on the filing and effectiveness of a registration statement. The debentures bear 4% annual interest and mature in September 2028.

Value
$30.9M
Counterparty
YA II PN, LTD. (Yorkville)
Term
2 years

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.